“…2 On the other hand, low levels of Aβ 1-42 in CSF may be also associated with other neurodegenerative diseases (NDs), notably dementia with Lewy body (DLB), Parkinson's disease (PDD) or Creutzfeld-Jacob disease (CJD). Different proposed biomarker combinations for AD include Aβ 1-42 and Tau/p-Tau protein, 5,6 Aβ 1-42/Aβ 1-40 ratio, 6,7 Aβ 1-42, Aβ 1-40 and Aβ 1-38, 8,9 the ratio of Aβ 1-42/(Aβ 1-42 + Aβ 1-40 + Aβ 1-38), 10 the ratio Aβ 1-40/42 and those between Aβ 1-37, Aβ 1-38 and Aβ 1-39 11,12 and Aβ 1-42 together with Aβ 2-42. Different proposed biomarker combinations for AD include Aβ 1-42 and Tau/p-Tau protein, 5,6 Aβ 1-42/Aβ 1-40 ratio, 6,7 Aβ 1-42, Aβ 1-40 and Aβ 1-38, 8,9 the ratio of Aβ 1-42/(Aβ 1-42 + Aβ 1-40 + Aβ 1-38), 10 the ratio Aβ 1-40/42 and those between Aβ 1-37, Aβ 1-38 and Aβ 1-39 11,12 and Aβ 1-42 together with Aβ 2-42.…”